
Welcome to AJC! | ajc.com — Isn’t the FDA supposed to be monitoring this sort of thing better? And I thought testing was supposed to take place BEFORE a drug was released, not during its release.
The maker of the popular arthritis drug Vioxx is removing it from markets worldwide after a new study found that long-term users face increased risks for heart attack and stroke.
The three-year study, designed to see if daily 25-milligram doses of Vioxx might inhibit recurrence of precancerous polyps in the colon and rectum, found the cardiovascular risks began to appear approximately 18 months after starting on the drug.






















